These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23843546)

  • 1. Should Europe have a universal hepatitis B vaccination programme?
    Van Damme P; Leuridan E; Hendrickx G; Vorsters A; Theeten H; Leino T; Salminen M; Kuusi M
    BMJ; 2013 Jul; 347():f4057. PubMed ID: 23843546
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine uptake rather than disease mitigation seems to be aim of universal hepatitis B vaccination in the UK.
    Puliyel J
    BMJ; 2013 Sep; 347():f5187. PubMed ID: 24004990
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study on immune efficacy in children immunized by hepatitis B vaccine in disease surveillance points of Fujian].
    Li L; Zhou Y; Zhao L; Xia S; Wang Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):372-4. PubMed ID: 15617252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparing for the next public debate: universal vaccination against hepatitis B.
    Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
    Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
    Luo Z; Li L; Ruan B
    Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake.
    Suckling RM; Taegtmeyer M; Nguku PM; Al-Abri SS; Kibaru J; Chakaya JM; Tukei PM; Gilks CF
    J Hosp Infect; 2006 Nov; 64(3):271-7. PubMed ID: 16926061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal hepatitis B vaccination.
    Kretzschmar M; de Wit A
    Lancet Infect Dis; 2008 Feb; 8(2):85-7; author reply 90. PubMed ID: 18222156
    [No Abstract]   [Full Text] [Related]  

  • 12. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
    Dunn J; Shukla R; Neal K
    BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
    Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
    Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal hepatitis B vaccination.
    Piazza M
    Lancet Infect Dis; 2008 Feb; 8(2):88-9; author reply 90. PubMed ID: 18222158
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective efficacy and antibody follow-up of hepatitis B vaccine within the South African expanded programme on immunisation.
    Mphahlele MJ; Tshatsinde EA; Burnett RJ; Aspinall S
    S Afr Med J; 2002 Aug; 92(8):612-3. PubMed ID: 12244619
    [No Abstract]   [Full Text] [Related]  

  • 16. Universal hepatitis B vaccination.
    Hahné S; Ramsay M; Coutinho R
    Lancet Infect Dis; 2008 Feb; 8(2):87-8; author reply 90. PubMed ID: 18222157
    [No Abstract]   [Full Text] [Related]  

  • 17. The reach of a hepatitis B vaccination programme among men who have sex with men.
    Baars JE; Boon BJ; Garretsen HF; van de Mheen D
    Eur J Public Health; 2011 Jun; 21(3):333-7. PubMed ID: 20813894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The worldwide impact of vaccination on the control and protection of viral hepatitis B.
    Romano' L; Paladini S; Van Damme P; Zanetti AR
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S2-7. PubMed ID: 21195368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis-B vaccination.
    Phadke A; Kale A
    J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.